190 related articles for article (PubMed ID: 16010588)
1. Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy.
Park SH; Lee WK; Chung M; Bang SM; Cho EK; Lee JH; Shin DB
Cancer Chemother Pharmacol; 2006 Feb; 57(3):289-94. PubMed ID: 16010588
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study.
Bezjak A; Tu D; Bacon M; Osoba D; Zee B; Stuart G; Roy JA; Piccart M; Eisenhauer E
J Clin Oncol; 2004 Nov; 22(22):4595-603. PubMed ID: 15466785
[TBL] [Abstract][Full Text] [Related]
3. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
4. Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus).
Carlson LE; Bultz BD; Morris DG
Health Qual Life Outcomes; 2005 Jan; 3():7. PubMed ID: 15676074
[TBL] [Abstract][Full Text] [Related]
5. Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy.
Iconomou G; Mega V; Koutras A; Iconomou AV; Kalofonos HP
Cancer; 2004 Jul; 101(2):404-11. PubMed ID: 15241840
[TBL] [Abstract][Full Text] [Related]
6. Evaluating cognitive, emotional, and physical fatigue domains in daily practice by single-item questions in patients with advanced cancer: a cross-sectional pragmatic study.
Strasser F; Müller-Käser I; Dietrich D
J Pain Symptom Manage; 2009 Oct; 38(4):505-14. PubMed ID: 19822275
[TBL] [Abstract][Full Text] [Related]
7. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
[TBL] [Abstract][Full Text] [Related]
9. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
[TBL] [Abstract][Full Text] [Related]
10. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
Browall MM; Ahlberg KM; Persson LO; Karlsson PO; Danielson EB
Acta Oncol; 2008; 47(2):207-15. PubMed ID: 18210297
[TBL] [Abstract][Full Text] [Related]
11. EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies: association with anxiety and depression.
Pamuk GE; Harmandar F; Ermantaş N; Harmandar O; Turgut B; Demir M; Vural O
Ann Hematol; 2008 Apr; 87(4):305-10. PubMed ID: 18219486
[TBL] [Abstract][Full Text] [Related]
12. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of quality of life, anxiety and depression in testicular cancer patients during chemotherapy and after anticancer treatment].
Osmańska M; Borkowska A; Makarewicz R
Psychiatr Pol; 2010; 44(4):543-56. PubMed ID: 20919505
[TBL] [Abstract][Full Text] [Related]
14. [A prospective longitudinal study examining the impact on short term quality of life of hand video-assisted thoracoscopic surgical esophagectomy in patients with esophageal cancer].
Guan QM; Du JJ; Meng L; Chen JH
Zhonghua Wai Ke Za Zhi; 2007 May; 45(10):688-91. PubMed ID: 17688822
[TBL] [Abstract][Full Text] [Related]
15. Quality of life after surgical treatment of gastric carcinoma.
Zieren HU; Zippel K; Zieren J; Müller JM
Eur J Surg; 1998 Feb; 164(2):119-25. PubMed ID: 9537719
[TBL] [Abstract][Full Text] [Related]
16. [Factors affecting quality of life of patients with gastrointestinal cancer].
Chen P; Wang HJ; Zhu L; Jia R; Jian HY
Ai Zheng; 2007 Oct; 26(10):1116-21. PubMed ID: 17927884
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of EORTC QLQ-C30 questionnaire in patients undergoing in-hospital chemotherapy for gastrointestinal cancer in Japan.
Kato J; Nagahara A; Iijima K; Yoshimura M; Osada T; Yoshizawa T; Watanabe S
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S268-72. PubMed ID: 19120910
[TBL] [Abstract][Full Text] [Related]
18. Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.
Van Steen K; Curran D; Kramer J; Molenberghs G; Van Vreckem A; Bottomley A; Sylvester R
Stat Med; 2002 Dec; 21(24):3865-84. PubMed ID: 12483772
[TBL] [Abstract][Full Text] [Related]
19. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
Lagergren P; Fayers P; Conroy T; Stein HJ; Sezer O; Hardwick R; Hammerlid E; Bottomley A; Van Cutsem E; Blazeby JM;
Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
[TBL] [Abstract][Full Text] [Related]
20. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study.
Bottomley A; Gaafar R; Manegold C; Burgers S; Coens C; Legrand C; Vincent M; Giaccone G; Van Meerbeeck J; ;
J Clin Oncol; 2006 Mar; 24(9):1435-42. PubMed ID: 16446322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
